Gene · 5324
Papers4,340
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,340
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current progress and challenges in the development of brain tissue models: How to grow up the changeable brain in vitro? | J Tissue Eng | 2024 | 38516227 | PubTator, text mining | PubMed |
| Characterization of a Molecularly Distinct Subset of Oncocytic Pleomorphic Adenomas/Myoepitheliomas Harboring Recurrent ZBTB47-AS1::PLAG1 Gene Fusion. | Am J Surg Pathol | 2024 | 38497430 | PubTator, text mining | PubMed |
| Diagnostic Value of GSTP1, RASSF1, AND RASSF2 Methylation in Serum of Prostate Cancer Patients. | Urol J | 2024 | 38493315 | PubTator, text mining | PubMed |
| An insight into the diagnostic, prognostic, and taxanes resistance of double zinc finger and homeodomain factor's expression in naïve prostate cancer. | 3 Biotech | 2024 | 38476644 | PubTator, text mining | PubMed |
| A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate Cancer Demonstrating "BRCAness" Genotype (ROAR). | Oncologist | 2024 | 38452035 | PubTator, text mining | PubMed |
| A rare Ewing-like small round cell tumor in prostate: a case report and literature review. | J Cancer Res Clin Oncol | 2024 | 38427070 | PubTator, text mining | PubMed |
| Pitfalls in Salivary Gland Cytology. | Acta Cytol | 2024 | 38417405 | PubTator, text mining | PubMed |
| Pleomorphic Adenoma with a Novel Gene Rearrangement-LINC01606::PLAG1. | Head Neck Pathol | 2024 | 38393488 | PubTator, text mining | PubMed |
| A new promising indicator in prostate cancer screening: Prostate-specific antigen fluctuation rate. | Actas Urol Esp (Engl Ed) | 2024 | 38369288 | PubTator, text mining | PubMed |
| Exploring the combinatorial explosion of amine-acid reaction space via graph editing. | Commun Chem | 2024 | 38310120 | PubTator, text mining | PubMed |
| Integration of network pharmacology, molecular docking, and simulations to evaluate phytochemicals from Drymaria cordata against cervical cancer. | RSC Adv | 2024 | 38292259 | PubTator, text mining | PubMed |
| Integrated analysis identifies GABRB3 as a biomarker in prostate cancer. | BMC Med Genomics | 2024 | 38287309 | PubTator, text mining | PubMed |
| Multiomic analysis implicates nuclear hormone receptor signalling in clustering epilepsy. | Transl Psychiatry | 2024 | 38280856 | PubTator, text mining | PubMed |
| Inhibiting the m6A Reader IGF2BP3 Suppresses Ovarian Cancer Cell Growth via Regulating PLAGL2 mRNA Stabilization. | World J Oncol | 2024 | 38274714 | PubTator, text mining | PubMed |
| SOX10-Internal Tandem Duplications and PLAG1 or HMGA2 Fusions Segregate Eccrine-Type and Apocrine-Type Cutaneous Mixed Tumors. | Mod Pathol | 2024 | 38266920 | PubTator, text mining | PubMed |
| First-in-human imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate. | medRxiv | 2024 | 38260492 | PubTator, text mining | PubMed |
| Modeling the Blood-Brain Barrier Permeability of Potential Heterocyclic Drugs via Biomimetic IAM Chromatography Technique Combined with QSAR Methodology. | Molecules | 2024 | 38257200 | PubTator, text mining | PubMed |
| ID2 Promotes Lineage Transition of Prostate Cancer through FGFR and JAK-STAT Signaling. | Cancers (Basel) | 2024 | 38254880 | PubTator, text mining | PubMed |
| Carboplatin and Etoposide for the Treatment of Metastatic Prostate Cancer with or without Neuroendocrine Features: A French Single-Center Experience. | Cancers (Basel) | 2024 | 38254771 | PubTator, text mining | PubMed |
| Establishment and Validation of a Four-stress Granule-related Gene Signature in Hepatocellular Carcinoma. | J Clin Transl Hepatol | 2024 | 38250470 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5324/papers?page=14